China Resources Boya Bio-pharmaceutical Group Co., Ltd.
SHZ: 300294.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yuxuan Pan
- Employees
- 1,938
- Headquarters
- Fuzhou, China
- IPO year
- 2012
- Market cap
- CN¥8.9B
- Website
- https://www.china-boya.com
Loading 300294…
Loading profile data…Frequently asked questions about 300294
What does China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ) do?
China Resources Boya Bio-pharmaceutical Group Co., Ltd. engages in the blood products, diabetes medication, biochemical medication, and chemical medicine businesses in China. It engages in the research and development, production, and sales of blood products comprising human fibrinogen, intravenous human immunoglobulin, rabies immunoglobulin, hu...
Where does 300294.SZ trade?
China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300294.SZ in?
China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of China Resources Boya Bio-pharmaceutical Group Co., Ltd.?
Yuxuan Pan is the chief executive officer of China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ).
Where is China Resources Boya Bio-pharmaceutical Group Co., Ltd. headquartered?
China Resources Boya Bio-pharmaceutical Group Co., Ltd. is headquartered in China.
Does 300294.SZ pay a dividend?
Yes — China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ) paid a trailing twelve-month dividend of CNY 0.31 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300294.SZ go public?
China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ) completed its initial public offering in 2012.